Retrospective multicenter evaluation of oral step-down versus intravenous carbapenem treatment of extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infections
Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)
DOI: 10.1017/ash.2026.10794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 24.07.2026. Verfasst von Margarita Bellon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, South Miami Hospital, South Miami, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This study evaluated whether treatment with oral step-down therapy compared with intravenous carbapenems alone for extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli urinary tract infections (UTIs) impacted patient venous catheter days and clinical outcomes.
Methods
This multicenter retrospective study at six different hospitals in a large health system included adults (≥ 18 years) admitted for ≥ 24 hours with ≥ 1 documented UTI symptom, a ceftriaxone-resistant Escherichia coli urine culture, and receipt of ≥ 1 dose of meropenem or ertapenem between August 2022 and July 2025. The primary outcome was median venous catheter line days directly associated with antibiotic use inpatient and outpatient. Secondary outcomes included pharmacist antibiotic intervention, incidence of antibiotic-related adverse events, hospital length of stay, duration of therapy, inpatient catheter line days, projected outpatient catheter line days, presence of peripherally inserted central catheter or midline, central line-associated bloodstream infection, and treatment failure (defined as escalation of antibiotics, in-hospital mortality, urgent care/emergency department visit or readmission, or recurrence of symptomatic UTI with ESBL Escherichia coli within 30 days).
Results
120 patients were included, with 60 in the oral step-down and carbapenem groups, respectively. Primary outcome of median venous catheter days in the oral step-down group was 0 (IQR 0–0) vs 5 (IQR 0–7) in the carbapenem group, p < .001. Secondary outcome of treatment failure in the oral step-down group was 2 (3%) vs 8 (13%) in the carbapenem group, p < .09.
Conclusions
Oral step-down therapy for ESBL Escherichia coli UTIs was associated with a significant reduction in venous catheter line use.
Autor:innen und Institutionen
- Department of Pharmacy, South Miami Hospital, South Miami, USA.
- Department of Medicine, South Miami Hospital, South Miami, USA.
- Baptist Health Academics, Baptist Health: Baptist Health South Florida Inc, Miami, USA.
- Clinical Pharmacy Enterprise, Baptist Health: Baptist Health South Florida Inc, Miami, USA.
ORCID-Profile: Margarita Bellon, Stephen Breazeale
Zitieren
APA
Bellon, M., Margulis Landayan, A., Morales, J., Murillo, J., Breazeale, S., & Gauthier, T. P. (2026). Retrospective multicenter evaluation of oral step-down versus intravenous carbapenem treatment of extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infections. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10794
Vancouver
Bellon M, Margulis Landayan A, Morales J, Murillo J, Breazeale S, Gauthier TP. Retrospective multicenter evaluation of oral step-down versus intravenous carbapenem treatment of extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infections. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10794
BibTeX
@article{Bellon2026,
author = {Bellon, Margarita and Margulis Landayan, Alice and Morales, Jorge and Murillo, Jorge and Breazeale, Stephen and Gauthier, Timothy P},
title = {Retrospective multicenter evaluation of oral step-down versus intravenous carbapenem treatment of extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infections},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1017/ash.2026.10794}
}
EUVIMED